FDA, NIST Join Forces To Improve Manufacturing, Quell Device Shortages
Executive Summary
The focus on innovative manufacturing will also include a new clearinghouse to share info about advanced manufacturing technology within the US agency’s device center.
You may also be interested in...
US FDA Presents 3D Printing Scenarios To Spark Discussion, Lead To Future Guidance
The agency recently published a paper to spark discussions in the medtech industry on how to best regulate 3D printing of medical devices at points of care such a clinics and hospitals.
3D-Printing Final Guidance Clarifies Manufacturing Practice Expectations
A year and a half after FDA issued a draft guidance to help makers of devices that rely on additive manufacturing, the agency has finalized the document in its bid to get ahead of the technology. The final guidance makes minor clarifications, but for the most is identical to the draft.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.